Medicare Enrolled
Dr. Aminder Mehdi, MD
Optician · Stockton, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Mehdi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mehdi?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Mehdi
Dr. Aminder Mehdi is an optician specialist in Stockton, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Mehdi performed 91,074 Medicare services across 2,530 unique beneficiaries.
Between the years covered by Open Payments, Dr. Mehdi received a total of $9,337 from 81 pharmaceutical and/or device companies across 391 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Mehdi is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 1% volume in CA
$9,337 industry payments
Medicare Practice Summary
Medicare Utilization ↗91,074
Medicare services
Top 1% in CA for optician
2,530
Unique beneficiaries
$22
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~4,793 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Oxaliplatin chemotherapy injection This procedure involves the administration of oxaliplatin, a chemotherapy medication, via injection. The dosage specified is 0.5 mg. |
22,900 | $0 | $16 |
| Pembrolizumab injection (Keytruda) | 22,000 | $43 | $165 |
| Denosumab injection (Prolia/Xgeva) | 16,440 | $18 | $69 |
| Paclitaxel chemotherapy injection | 14,362 | $0 | $20 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
3,928 | $0 | $18 |
| Anti-nausea injection (Aloxi/palonosetron) | 2,010 | $1 | $32 |
| Injection, leucovorin calcium, per 50 mg | 985 | $3 | $33 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
707 | $100 | $389 |
| Fluorouracil injection, 500 mg Administration of a 500 mg dose of fluorouracil medication via injection. |
641 | $2 | $31 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
639 | $111 | $418 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
614 | $25 | $92 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
505 | $2 | $35 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
502 | $12 | $46 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
483 | $13 | $52 |
| Pegfilgrastim-apgf injection An injection of pegfilgrastim-apgf, a biosimilar medication. The dose specified is 0.5 mg. |
480 | $102 | $524 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
442 | $8 | $35 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
349 | $24 | $90 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
316 | $140 | $546 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
308 | $1 | $32 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
224 | $70 | $270 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
219 | $55 | $206 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
190 | $8 | $27 |
| Piflufolastat F-18 diagnostic injection A diagnostic injection of the radioactive tracer piflufolastat F-18 used for imaging. The dose specified is 1 millicurie. |
153 | $488 | $2,275 |
| Nuclear medicine scan from skull base to mid-thigh with CT A nuclear medicine imaging study covering the area from the base of the skull to the middle of the thighs, performed alongside a CT scan. |
140 | $1,363 | $5,029 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 138 | $274 | $1,082 |
| New patient office visit, complex (60-74 min) | 136 | $165 | $646 |
| Concurrent intravenous infusion Administration of medication or fluid into a vein for therapy, prevention, or diagnosis while another infusion is being given. |
134 | $17 | $63 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
133 | $11 | $40 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
125 | $54 | $209 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
118 | $20 | $88 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
107 | $97 | $349 |
| IV chemotherapy initiation with community continuation Initiation of an intravenous chemotherapy infusion in a clinic using clinic supplies, with continuation of the infusion in a community setting such as home or assisted living. |
91 | $147 | $473 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
81 | $48 | $173 |
| Injection, fosnetupitant 235 mg and palonosetron 0.25 mg | 81 | $353 | $1,350 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
72 | $65 | $230 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
63 | $28 | $100 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
60 | $28 | $117 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
49 | $2 | $32 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
48 | $1 | $33 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
41 | $141 | $514 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
34 | $127 | $473 |
| Whole body nuclear medicine scan with CT A combined imaging procedure using nuclear medicine and CT scans to visualize the entire body. |
15 | $1,383 | $4,785 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
11 | $87 | $354 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
2.1% high complexity
95.0% medium
2.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$9,337
Total received (2018-2024)
Avg $1,334/year across 7 years
Top 15% in CA for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
81
Companies
391
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,935 (85.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,129 (12.1%)
Other
Charitable contributions, space rental, and other categories
$272 (2.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,495
2023
$1,197
2022
$1,158
2021
$1,193
2020
$1,213
2019
$2,289
2018
$791
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$272
Janssen Biotech, Inc.
$206
BeiGene USA, Inc.
$107
Lilly USA, LLC
$79
SpringWorks Therapeutics, Inc.
$63
AstraZeneca Pharmaceuticals LP
$57
Incyte Corporation
$54
Regeneron Healthcare Solutions, Inc.
$52
E.R. Squibb & Sons, L.L.C.
$50
PFIZER INC.
$49
Genmab U.S., Inc.
$49
ABBVIE INC.
$40
Azurity Pharmaceuticals, Inc.
$37
GlaxoSmithKline, LLC.
$32
Myriad Genetic Laboratories, Inc.
$31
TAIHO ONCOLOGY, INC.
$31
Rigel Pharmaceuticals, Inc.
$30
Genentech USA, Inc.
$28
Gilead Sciences, Inc.
$27
Telix Pharmaceuticals
$27
Takeda Pharmaceuticals U.S.A., Inc.
$25
Celgene Corporation
$25
ADC Therapeutics America, Inc.
$24
Invivyd Inc
$23
SERVIER PHARMACEUTICALS LLC
$23
Merck Sharp & Dohme LLC
$21
Fennec Pharmaceuticals, Inc.
$19
Amgen Inc.
$14
Top 3 companies account for 39.1% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$1,996
Janssen Biotech, Inc.
$757
PFIZER INC.
$457
Pharmacyclics LLC, An AbbVie Company
$379
E.R. Squibb & Sons, L.L.C.
$353
Seagen Inc.
$293
Celgene Corporation
$263
Genentech USA, Inc.
$239
Gilead Sciences, Inc.
$228
Astellas Pharma US Inc
$223
ABBVIE INC.
$212
GENZYME CORPORATION
$211
BeiGene USA, Inc.
$206
Lilly USA, LLC
$190
AstraZeneca Pharmaceuticals LP
$174
Regeneron Healthcare Solutions, Inc.
$154
Amgen Inc.
$149
Exelixis Inc.
$116
GlaxoSmithKline, LLC.
$106
Takeda Pharmaceuticals U.S.A., Inc.
$100
Incyte Corporation
$100
Octapharma USA, Inc.
$98
Kite Pharma, Inc.
$96
Merck Sharp & Dohme Corporation
$93
Daiichi Sankyo Inc.
$80
Genmab U.S., Inc.
$80
Karyopharm Therapeutics Inc.
$78
Stemline Therapeutics Inc.
$72
Bayer HealthCare Pharmaceuticals Inc.
$71
Boehringer Ingelheim Pharmaceuticals, Inc.
$71
Rigel Pharmaceuticals, Inc.
$67
SpringWorks Therapeutics, Inc.
$63
Merck Sharp & Dohme LLC
$61
ARRAY BIOPHARMA INC
$59
Blueprint Medicines Corporation
$59
Myovant Sciences Inc.
$54
Puma Biotechnology, Inc.
$52
Eisai Inc.
$52
Taiho Oncology, Inc.
$51
Clovis Oncology, Inc.
$51
Dendreon Pharmaceuticals LLC
$46
NOVARTIS PHARMACEUTICALS CORPORATION
$44
SERVIER PHARMACEUTICALS LLC
$41
MorphoSys, US Inc.
$41
TerSera Therapeutics LLC
$38
AbbVie, Inc.
$38
Azurity Pharmaceuticals, Inc.
$37
Sun Pharmaceutical Industries Inc.
$35
PUMA BIOTECHNOLOGY, INC.
$34
Medtronic, Inc.
$33
Teva Pharmaceuticals USA, Inc.
$33
Heron Therapeutics, Inc.
$32
Myriad Genetic Laboratories, Inc.
$31
TAIHO ONCOLOGY, INC.
$31
EMD Serono, Inc.
$30
Pharmacyclics LLC, an AbbVie Company
$30
AMAG Pharmaceuticals, Inc.
$28
Agios Pharmaceuticals, Inc.
$28
Aurobindo Pharma USA, Inc.
$28
Telix Pharmaceuticals
$27
Janssen Pharmaceuticals, Inc
$27
Acrotech Biopharma LLC
$26
PharmaEssentia USA Corporation
$25
Array BioPharma Inc.
$24
Helsinn Therapeutics (U.S.), Inc.
$24
ADC Therapeutics America, Inc.
$24
Partner Therapeutics, Inc.
$24
Sumitomo Pharma America, Inc.
$23
Invivyd Inc
$23
Kyowa Kirin, Inc.
$21
Servier Pharmaceuticals LLC
$21
Blue Earth Diagnostics Limited
$21
GE HealthCare
$20
Sobi, Inc
$20
Jazz Pharmaceuticals Inc.
$20
Fennec Pharmaceuticals, Inc.
$19
Epizyme, Inc.,
$19
Ipsen Biopharmaceuticals, Inc
$17
Secura Bio, Inc.
$14
SECURA BIO, INC.
$13
Seattle Genetics, Inc.
$13
Top 3 companies account for 34.4% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AKYNZEO · Abraxane · Aliqopa · Axumin · BAVENCIO · BELEODAQ · BENDEKA · BESREMI · BOSULIF · BRACANALYSIS CDX · BRAFTOVI · BRUKINSA · Braftovi · CALQUENCE · CINVANTI · COPIKTRA · COSELA · CRESEMBA · CYRAMZA · Cabometyx · Cinvanti · DARZALEX · DOPTELET · ELIQUIS · ELITEK · ELZONRIS · EMPLICITI · ENHERTU · ERLEADA · EVENITY · EXKIVITY · Enhertu · Epkinly · Erleada · FERAHEME · FRUZAQLA · Fabhalta · Farydak · Folotyn · GAVRETO · GAZYVA · GILOTRIF · IBRANCE · ILLUCCIX · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INREBIC · Imbruvica · JAKAFI · JEVTANA · KEYTRUDA · KISQALI · Kadcyla · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LYNPARZA · Lenvima · Leukine · Lonsurf · Lunsumio · Lupron · MEKINIST · MONJUVI · MYRISK · NERLYNX · NINLARO · Nerlynx · Nplate · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OGSIVEO · OJJAARA · ONUREG · OPDIVO · ORGOVYX · OSTEOCOOL RF ABLATION SYSTEM · Orserdu · PADCEV · PEMGARDA · PIQRAY · POTELIGEO · PROMACTA · PROVENGE · Pedmark · Perjeta · REBLOZYL · RYBREVANT · Revlimid · Rezlidhia · Rubraca · SARCLISA · SCEMBLIX · SPRYCEL · SUTENT · Somatuline Depot · TAGRISSO · TALVEY · TALZENNA · TASIGNA · TAZVERIK · TECENTRIQ · TIBSOVO · TIVDAK · TRIPTODUR · TUKYSA · Tavalisse · Tecentriq · Tibsovo · Trodelvy · Truxima · VENCLEXTA · VERZENIO · VIVIMUSTA · VOTRIENT · VYXEOS · Venclexta · Vitrakvi · WILATE - VON WILLEBRAND FACTOR/COAGULATION FACTOR VIII COMPLEX (HUMAN) · XALKORI · XARELTO · XPOVIO · XTANDI · Xospata · Xtandi · YONSA · Yescarta · ZEJULA · ZYTIGA · Zevalin · Zoladex
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (85%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Opticians within 10 mi
84
Per 100K population
10.7
County median income
$88,531
Nearest hospital
ST JOSEPH'S MEDICAL CENTER OF STOCKTON
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Mehdi is a mixed practice specialist, with above-average Medicare volume (top 1% in CA), with low-engagement industry engagement in the top 15% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Mehdi experienced with oxaliplatin chemotherapy injection?
Based on Medicare claims data, Dr. Mehdi performed 22,900 oxaliplatin chemotherapy injection services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Mehdi receive payments from pharmaceutical companies?
Yes. Dr. Mehdi received a total of $9,337 from 81 companies across 391 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mehdi's costs compare to other opticians in Stockton?
Dr. Mehdi's average Medicare payment per service is $22. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mehdi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in Stockton
Browse opticians in Stockton ranked by procedure volume and transparency data.
Highest volume
Top Opticians in CA
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in CA
Which CA opticians receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology